Back to results
US 9,801,868 B2Granted
5-substituted isoindoline compounds
AssigneeCelgene Corporation
InventorsGeorge W. Muller, Roger Shen-Chu Chen, Alexander L. Ruchelman
Life of this patent
Estimating the term…
Abstract
This invention relates to 5-substituted isoindoline compounds, and pharmaceutically acceptable salts, solvates, stereoisomers, and prodrugs thereof. Methods of use, and pharmaceutical compositions of these compounds are disclosed.
Claims3
A method of treating or managing a disease or disorder which comprises administering to a patient in need of such treatment or management a therapeutically effective amount of a compound of formula (I):
- or a pharmaceutically acceptable salt, solvate, or stereoisomer thereof, wherein:
- X is CH2 or C═O;
- Z is:
- (CH2)m, wherein m is 0 or 1;
- or NH;
- R1 is halogen or (C1-C6)alkyl, itself optionally substituted with one or more halogen;
- and
- R2 is hydrogen;
- halogen;
- or (C1-C6)alkyl, itself optionally substituted with one or more halogen;
- and
- wherein the disease or disorder is cancer or a disorder associated with angiogenesis.
9 more elements
Dependencies are inferred from the claim text.